Argatroban (Gland Pharma Limited)


Welcome to the PulseAid listing for the Argatroban drug offered from Gland Pharma Limited. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Gland Pharma Limited
NON-PROPRIETARY NAME: Argatroban
SUBSTANCE NAME: ARGATROBAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-05-26
END MARKETING DATE: 0000-00-00


Argatroban HUMAN PRESCRIPTION DRUG Details:

Item DescriptionArgatroban from Gland Pharma Limited
LABELER NAME: Gland Pharma Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 125(mg/125mL)
START MARKETING DATE: 2017-05-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68083-141_69efc0d6-1280-4920-b920-c56bfc353602
PRODUCT NDC: 68083-141
APPLICATION NUMBER: ANDA205570

Other ARGATROBAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Eagle Pharmaceuticals, Inc.Argatroban
Fresenius Kabi USA, LLCArgatroban
Gland Pharma LimitedArgatroban
GlaxoSmithKline LLCARGATROBAN
Hospira, Inc.Argatroban
Par Pharmaceutical, Inc.Argatroban
Sandoz IncArgatroban
Teva Parenteral Medicines, Inc.Argatroban
West-Ward Pharmaceuticals CorpArgatroban